Suchergebnisse - "Yao, Hang-Ping"

PubPharm (13)

1

RON Receptor Tyrosine Kinase in Tumorigenic Stemness as a Therapeutic Target of Antibody-drug Conjugates for Eradication of Triple-negative Breast Cancer Stem Cells

enthalten in: Current cancer drug targets | 2023

von Suthe, S. | Yao, H. | Weng, T. | +1

2

Antibody-drug Conjugate PCMC1D3-Duocarmycin SA as a Novel Therapeutic Entity for Targeted Treatment of Cancers Aberrantly Expressing MET Receptor Tyrosine Kinase

enthalten in: Current cancer drug targets | 2022

von Hudson, R. | Yao, H. | Suthe, S. | +2

3

Duocarmycin-based antibody-drug conjugates as an emerging biotherapeutic entity for targeted cancer therapy : Pharmaceutical strategy and clinical progress

enthalten in: Drug discovery today | 2021

von Yao, H. | Zhao, H. | Hudson, R. | +2

4

RON in hepatobiliary and pancreatic cancers : Pathogenesis and potential therapeutic targets

enthalten in: World journal of gastroenterology | 2021

von Chen, S. | Wang, G. | Shi, D. | +3

5

Pharmaceutical strategies in the emerging era of antibody-based biotherapeutics for the treatment of cancers overexpressing MET receptor tyrosine kinase

enthalten in: Drug discovery today | 2021

von Yao, H. | Tong, X. | Wang, M.

6

MET and RON receptor tyrosine kinases in colorectal adenocarcinoma : molecular features as drug targets and antibody-drug conjugates for therapy

enthalten in: Journal of experimental & clinical cancer research : CR | 2020

von Yao, H. | Tong, X. | Hudson, R. | +1

7

Antibody-drug conjugates targeting RON receptor tyrosine kinase as a novel strategy for treatment of triple-negative breast cancer

enthalten in: Drug discovery today | 2020

von Yao, H. | Suthe, S. | Hudson, R. | +1

8

RON receptor tyrosine kinase in pancreatic ductal adenocarcinoma : Pathogenic mechanism in malignancy and pharmaceutical target for therapy

enthalten in: Biochimica et biophysica acta. Reviews on cancer | 2020

von Yao, H. | Hudson, R. | Wang, M.

9

Therapeutic efficacy of a novel humanized antibody-drug conjugate recognizing plexin-semaphorin-integrin domain in the RON receptor for targeted cancer therapy

enthalten in: Journal for immunotherapy of cancer | 2019

von Tong, X. | Feng, L. | Suthe, S. | +6

10

Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapy

enthalten in: Journal for immunotherapy of cancer | 2019

von Yao, H. | Feng, L. | Suthe, S. | +9

ErratumIn: J Immunother Cancer. 2019 Apr 2;7(1):94. - PMID 30940188